In 2017, we have the advantage of, having available to us, 4 large clinical trials. All of the phase IV studies that have been published over the last few years review the use of novel oral ...

For patients who are scheduled for surgery, warfarin therapy should be discontinued 5 to 6 days before the procedure. 26 In patients who are at high risk for developing blood clots, the clinician may ...

April 18th 2017EP. 2: Differentiation of Direct Oral Anticoagulants for Nonvalvular Atrial Fibrillation April 18th 2017EP. 3: Treatment With Direct Oral Anticoagulants for Nonvalvular Atrial ...

A new study examined more than 5100 adults with nonvalvular AF who were starting oral anticoagulation therapy. Patients were divided into 4 groups, each with different baseline clinical ...

Apixaban may be safer and more effective than rivaroxaban for treating nonvalvular atrial fibrillation (AF), a new observational study suggests. The study, one of the largest to compare the two drugs ...

“To the best of our knowledge, this is the first study to have demonstrated the preventive effect of AF ablation on long-term AF-related cardiovascular events in very old patients with NVAF.” “We ...

Retrospective data support use of oral anticoagulants for death and MACE risk reduction in patients with end-stage kidney disease and nonvalvular atrial fibrillation who have an elevated CHA2DS2-VASc ...

Please provide your email address to receive an email when new articles are posted on . Label-concordant dosing may benefit patients on dialysis with nonvalvular atrial fibrillation more than ...

The association between frailty and clinical outcomes in older adults with NVAF hasn’t been thoroughly examined in real-world settings. New data finds frailty to be associated with cardiovascular and ...

Each month, The Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. The American Heart ...